Netherlands: NLC records two exits – Serda Therapeutics and Sanmirna

NLC Health Ventures, Netherlands-based early-stage healthtech venture investor and operator, has sold its shareholding in Serda Therapeutics  in a transaction paid fully in cash....

Denmark: SOL enters Nordics with acquisition of Nowus Healthcare

Italy-based SOL Group, a multinational producer of technical, pure and medical gases, has entered the Nordic market with the acquisition of 100% of Danish...

Germany: Chad Nikel appointed as new CEO of hg medical

Chad Nikel has been appointed as the new CEO of hg medical, a Germany-based global contract manufacturer of complex orthopaedic implants. Nikel brings experience on...

Italy: G Square acquires majority shareholding in Valtecne with view to delisting

G Square, an investment firm specialising in the healthcare sector, is acquiring approximately 82% of the share capital of Valtecne, an Italy-based listed contract...

UK: HB Fuller seals acquisition of AMS for £715m

New York-listed HB Fuller, the world’s largest pureplay adhesives company, is acquiring London-listed Advanced Medical Solutions Group, a UK-based world-leading specialist in tissue-healing technologies,...

Germany: DHCare taking next step in European mobility solutions with agreement to carve out...

DHCare, an international leader in designing, manufacturing and distributing medical devices in the mobility and post-acute care sectors, has signed a definitive agreement to...

US: CVC Catalyst to acquire majority stake in WillowWood from Blue Sea Capital, the...

CVC Catalyst III has agreed to acquire a majority stake in US-based WillowWood, one of the leading manufacturers of prosthetic products, from Blue Sea...

Denmark: Asker to discontinue acquisition of Kirstine Hardam

Asker Healthcare Group and KMT Medical Europe, the owner of Kirstine Hardam, have  agreed to discontinue the transaction of Hardam that was announced in...

US: Resmed expands clinical sleep health portfolio with completion of Noctrix Health acquisition

NYSE and ASX-listed Resmed, a US-based sleep health technology company, has completed its acquisition of Noctrix Health, a US-based medical device company developing clinically...

Lauxera doubles down on European Healthtech scale-up with €520m Fund II close

Lauxera Capital Partners has closed its second growth fund at €520m (US$605m), surpassing its €500m hard cap and nearly doubling the size of its...
Advertisement